Status:
COMPLETED
Directly Observed Hepatitis C Treatment in Methadone Clinics
Lead Sponsor:
Albert Einstein College of Medicine
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Hepatitis C
Medication Adherence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Drug users account for a disproportionately large burden of hepatitis C virus (HCV) infection. However, HCV treatment adherence rates in drug users may be suboptimal in patients who use drugs regularl...
Eligibility Criteria
Inclusion
- HCV-infected
- receive HCV medical care at the methadone clinic
- plan to initiate HCV treatment on-site within the next 3 months
- psychiatrically stable as determined by HCV treatment provider and/or on-site psychiatrist
- attend the methadone clinic between three and six days per week to receive methadone
- stable dose fo methadone for two weeks prior to the baseline visit
Exclusion
- unable or unwilling to provide informed consent
- currently receiving HCV treatment
- primary HCV care provider does not agree to their participation in the trial
- psychiatrically unstable
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01442311
Start Date
October 1 2007
End Date
March 1 2013
Last Update
June 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Albert Einstein College of Medicine Division of Substance Abuse
The Bronx, New York, United States, 10461